Issued 2026-09-16 at $38.61 · now $38.61 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, NC has typically landed between $32.83 and $47.15 — a range of −15.0% to +22.1% from the issuance price $38.61.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,673 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($38.61) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where NC has typically landed a month from the 2026-09-16 close of $38.61 — the range is history, not a prediction.
- now $38.61 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $38.98 (+1.0%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $36.3–$41.67
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $32.83–$47.15
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2009-02-09 | −60.5% | −62.6% | +0.0% |
| 2009-02-06 | −59.4% | −62.6% | +0.0% |
| 2009-02-05 | −59.1% | −59.1% | +9.4% |
| 3 best | |||
| 2009-03-11 | +153.0% | +0.0% | +153.0% |
| 2009-03-05 | +144.3% | −5.5% | +144.3% |
| 2017-09-13 | +120.4% | +0.0% | +120.4% |
4,673 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Loveman Elizabeth | officer | Sale | 1,662 @ $51.44 | $85K | −10.0% of holding | −9.1% | not yet — horizon still open | 14,999 | Form 4 · filed 3 days after the trade |
| 2026-03-12 | Loveman Elizabeth | officer | Sale | 4,053 @ $52.04 | $211K | −19.6% of holding | −9.8% | not yet — horizon still open | 16,661 | Form 4 · filed 4 days after the trade |
| 2026-03-09 | Maxwell Thomas A | officer | Sale | 1,785 @ $48.55 | $87K | −23.1% of holding | −0.6% | not yet — horizon still open | 5,944 | Form 4 · filed same day |
| 2025-11-12 | Loveman Elizabeth | officer | Sale | 1,897 @ $49.94 | $95K | −9.5% of holding | −1.0% | −9.7% | 18,172 | Form 4 · filed 1 day after the trade |
| 2025-11-10 | Loveman Elizabeth | officer | Sale | 2,997 @ $45.22 | $136K | −13.0% of holding | +5.9% | −1.3% | 20,069 | Form 4 · filed 2 days after the trade |
| 2025-09-04 | Loveman Elizabeth | officer | Sale | 3,208 @ $39.18 | $126K | −12.2% of holding | +1.4% | +20.0% | 23,066 | Form 4 · filed 1 day after the trade |
| 2025-05-21 | Maxwell Thomas A | officer | Sale | 4,123 @ $36.18 | $149K | −40.1% of holding | +5.5% | +17.8% | 6,155 | Form 4 · filed 1 day after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
293 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | LABARRE DENNIS W | director | Award / grant | 569 | 44,953 | Form 4 |
| 2026-07-01 | McDonald William Paul | director | Award / grant | 569 | 7,699 | Form 4 |
| 2026-07-01 | Miller Michael Sidney | director | Award / grant | 569 | 28,321 | Form 4 |
| 2026-07-01 | TAPLIN BRITTON T | director | Award / grant | 569 | 67,169 | Form 4 |
| 2026-07-01 | TAPLIN BRITTON T | director | Award / grant | 569 | 67,169 | Form 4 |
| 2026-07-01 | DALRYMPLE JOHN S III | director | Award / grant | 569 | 26,305 | Form 4 |
| 2026-07-01 | Jumper John P | director | Award / grant | 773 | 34,456 | Form 4 |
| 2026-07-01 | Miller Michael Sidney | director | Award / grant | 569 | 28,321 | Form 4 |
| 2026-07-01 | LABARRE DENNIS W | director | Award / grant | 569 | 44,953 | Form 4 |
| 2026-07-01 | McDonald William Paul | director | Award / grant | 569 | 7,699 | Form 4 |
| 2026-07-01 | SACHS VALERIE GENTILE | director | Award / grant | 569 | 11,021 | Form 4 |
| 2026-07-01 | SHAPARD ROBERT S | director | Award / grant | 569 | 18,750 | Form 4 |
| 2026-07-01 | RANKIN ALFRED M ET AL | director | Award / grant | 760 | 217,720 | Form 4 |
| 2026-07-01 | DALRYMPLE JOHN S III | director | Award / grant | 569 | 26,305 | Form 4 |
| 2026-07-01 | RANKIN VICTOIRE G | other | Award / grant | 760 | 217,720 | Form 4 |
| 2026-07-01 | RANKIN MATTHEW M | director | Award / grant | 569 | 37,875 | Form 4 |
| 2026-07-01 | RANKIN ELIZABETH B | other | Award / grant | 569 | 37,875 | Form 4 |
| 2026-07-01 | RANKIN ALFRED M ET AL | director | Award / grant | 760 | 217,720 | Form 4 |
| 2026-07-01 | RANKIN ELIZABETH B | other | Award / grant | 569 | 37,875 | Form 4 |
| 2026-07-01 | RANKIN MATTHEW M | director | Award / grant | 569 | 37,875 | Form 4 |
| 2026-07-01 | RANKIN VICTOIRE G | other | Award / grant | 760 | 217,720 | Form 4 |
| 2026-07-01 | SACHS VALERIE GENTILE | director | Award / grant | 569 | 11,021 | Form 4 |
| 2026-07-01 | SHAPARD ROBERT S | director | Award / grant | 569 | 18,750 | Form 4 |
| 2026-07-01 | Jumper John P | director | Award / grant | 773 | 34,456 | Form 4 |
| 2026-04-01 | RANKIN VICTOIRE G | other | Award / grant | 955 | 216,960 | Form 4 |
| 2026-04-01 | McDonald William Paul | director | Award / grant | 563 | 7,130 | Form 4 |
| 2026-04-01 | TAPLIN BRITTON T | director | Award / grant | 563 | 66,600 | Form 4 |
| 2026-04-01 | Miller Michael Sidney | director | Award / grant | 563 | 27,752 | Form 4 |
| 2026-04-01 | DALRYMPLE JOHN S III | director | Award / grant | 563 | 25,736 | Form 4 |
| 2026-04-01 | LABARRE DENNIS W | director | Award / grant | 563 | 44,384 | Form 4 |
| 2026-04-01 | Jumper John P | director | Award / grant | 563 | 33,683 | Form 4 |
| 2026-04-01 | RANKIN MATTHEW M | director | Award / grant | 563 | 37,306 | Form 4 |
| 2026-04-01 | RANKIN ELIZABETH B | other | Award / grant | 563 | 37,306 | Form 4 |
| 2026-04-01 | TAPLIN BRITTON T | director | Award / grant | 563 | 66,600 | Form 4 |
| 2026-04-01 | Miller Michael Sidney | director | Award / grant | 563 | 27,752 | Form 4 |
| 2026-04-01 | SHAPARD ROBERT S | director | Award / grant | 563 | 18,181 | Form 4 |
| 2026-04-01 | SACHS VALERIE GENTILE | director | Award / grant | 563 | 10,452 | Form 4 |
| 2026-04-01 | McDonald William Paul | director | Award / grant | 563 | 7,130 | Form 4 |
| 2026-04-01 | SHAPARD ROBERT S | director | Award / grant | 563 | 18,181 | Form 4 |
| 2026-04-01 | RANKIN VICTOIRE G | other | Award / grant | 955 | 216,960 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.